Dr. Loizidis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
443 Laurel Oak Rd
Ste 130
Voorhees, NJ 08043Phone+1 856-741-0122Fax+1 856-741-0121
Education & Training
University of AthensClass of 2012
University of Pennsylvania Health SystemFellowship, Rheumatology- University of Pennsylvania Health SystemResidency, Internal Medicine
Certifications & Licensure
WA State Medical License 2023 - 2026
NJ State Medical License 2018 - 2025
NY State Medical License 2023 - 2025
OR State Medical License 2023 - 2025
PA State Medical License 2017 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Mortality and Health Outcomes Among Patients With Sarcoidosis Treated With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.Joseph Fares, Omar El Fadel, Joy Zhao, Jianxin Sun, Jesse Roman
Chest. 2024-09-21 - Letter to the editor in response to article "Use of statins in patients with established idiopathic inflammatory myopathies".Joseph Fares, Ross Summer, Giorgos Loizidis
Clinical Rheumatology. 2024-07-01 - 2 citationsLow utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023).Joseph Fares, Ross Summer, Giorgos Loizidis
Clinical Rheumatology. 2024-01-01
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
